3rd Quarter - Amendment
EAST END GROUP, LLC for ALVOGEN
Firm
Client
Income
$45,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 19, 2022 | $45,000 | Replaced |
| 3rd Quarter - Amendment | Jun 28, 2023 | $45,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Dec 11, 2023 | $45,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Foreign entity interest: Alvogen Luxembourg SARL; Temasek Singapore
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY CHILDRESS LANGE | Rep. Shimkus, LA; Rep. Rogers, Health Policy Adviser. |
| ANDREW HAWKINS | Rep. Rogers, LA, Chief of Staff. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.